Local delivery of 17β-estradiol improves reendothelialization and decreases inflammation after coronary stenting in a porcine model

Thrombosis and Haemostasis

Volumn 94, Issue 5, 2005, Pages 1042-1047

  Chandrasekar, Baskaran ^a   Sirois, Martin G ^a,b   Geoffroy, Pascale ^a   Lauzier, Dominique ^a   Nattel, Stanley ^a,b   Tanguay, Jean François ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Coronary disease; Hormones; Inflammation; Restenosis; Stents

Indexed keywords

DRUG VEHICLE; ESTRADIOL;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL DIAMETER; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR ENDOTHELIUM; ANIMAL; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; DRUG EFFECT; FEMALE; IMMUNOLOGY; PATHOLOGY; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULITIS; WOUND HEALING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; MALE; STENTS; SUS SCROFA; VASCULITIS; WOUND HEALING;

EID: 27844607407     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-12-0823     Document Type: Article

References (28)

1. Fischman DL, Leon MB, Baim DS et al. for the Stent Restenosis Study Investigators. A randomized comparision of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F et al. for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
3. Hoffmann R, Mintz GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.
4. Sullivan Jr TR, Karas RE, Aronovitz M et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96: 2482-8.
5. Chen SJ, Li H, Durand J et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996; 93: 577-84.
6. Chandrasekar B, Tanguay JF. Local delivery of 17-beta estradiol decreases neointimal hyperplasia following coronary angioplasty in porcine model. J Am Coll Cardiol 2000; 36: 1972-8.
7. Moura A, Lam JYT, Hebert D et al. Intramural delivery of agent via a novel drugdelivery sleeve: histological and functional evaluation. Circulation 1995; 92: 2299305.
8. Hong MK, Kent KM, Mehran R et al. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation 1997; 95: 449-54.
9. Wolf E, Roser K, Hahn M et al. Enzyme and immmnohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic: a new embedding method for routine application. Virchows Archiv A Pathol Anat 1992; 420: 17-24.
10. Carter AJ, Laird JR, Farb A et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994; 24: 1398-405.
11. Schwartz RS, Huber KC, Murphy JG et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-74.
12. Geraldes P, Sirois MG, Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res. 2003; 93: 399-405.
13. Iafrati MD, Karas RH, Aronovitz M et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 1997; 3: 545-8.
14. Karas RH, Hodgin JB, Kwoun M et al. Estrogen inhibits the vascular injury response in estrogen receptor b-deficient female mice. Proc Natl Acad Sci USA 1999; 96: 151336.
15. New G, Moses JW, Roubin GS et al. Estrogen-eluting, phosphorylcoline-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Cathet Cardiovasc Intervent 2002; 57: 266-71
16. Abizaid A, Albertal M, Costa M et al. First Human Experience With the 17-Beta-Estradiol-Eluting Stent. J Am Coll Cardiol 2004; 43: 1118-21.
17. Kornowski R, Hong MK, Tio FO et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-30.
18. Miller DD, Karim MA, Edwards WD et al. Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placement. Atherosclerosis 1996; 124: 145-55.
19. Garcia-Duran M, de Frutos T, Diaz-Recasens J et al. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res 1999; 85: 1020-6.
20. Miyamoto N, Mandai M, Suzuma I et al. Estrogen protects against cellular infiltration by reducing the expression of E-selectin and IL6 in endotoxin-induced uveitis. J Immunol 1999; 163: 374-9.
21. Kastrati A, Koch W, Berger PB et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36: 2168-73.
22. Weiner CP, Lizasoain I, Baylis SA et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-6.
23. Hayashi T, Yamada K, Esaki T et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995; 214: 847-55.
24. Chandrasekar B, Nattel S, Tanguay JF. Coronary artery endothelial protection following local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacological approach to improve endothelial function. J Am Coll Cardiol 2001; 38: 1570-6.
25. Cornwell TL, Arnold E, Boerth NJ et al. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 1994; 267: C1405-13.
26. Varenne O, Pislaru S, Gillijns H et al. Local adenovirus - mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 1998; 98: 916-26.
27. Murad F, Kuret JA. Estrogens and progestins. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors, The Pharmacological Basis of Therapeutics, New York: Pergamon Press 1990; 1384-412.
28. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.